Noble

Noble is excited to attend and display at this year’s HFES conference in New Orleans March 20-23. Connect with us at booth 7 during the conference to chat about our Human Factors + offering for clients as well as our robust patient training and onboarding solutions.

As are getting ready to hit the market in droves in the next few years, the EU, particularly Norway according to this analysis, has demonstrated successful strategies for making these biosimilars available to patients while also realizing monetary savings. Learn more:

Norway 'excellent example' of how to increase access to biosimilars The European Union, and specifically Norway, has demonstrated successful strategies for making biosimilars available for patients — and realizing “tremendous savings” — that should be adopted in the United States, according to an analysis. “With exception of the Kaiser...